Läkemedelsindustriföreningen is the trade association for the research-based pharmaceutical industry in Sweden with about 90 members and associate companies who represent approximately 80 percent of the total sales of pharmaceuticals in Sweden. LIF Service AB (LIF) represents its members in issues of common concern, assisting and informing them on questions vital to the industry. We are members of the European trade association EFPIA and the international trade association IFPMA as well as of the European associations AESGP.
The Board of our trade association consists of representatives of the member companies, under the chairmanship of Niklas Karlberg from Novartis. The Director General is Mr Anders Blanck.
LIF's Strategic objectives 2019-2022
- Top country in Europe for patients’ access to modern therapies.
- Regained leading position in industry initiated R&D.
- Sustainable & evidence based healthcare system.
- Pharma recognized as an essential partner to healthcare.